Processa Pharmaceuticals, Inc.

NasdaqCM:PCSA 株式レポート

時価総額:US$5.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Processa Pharmaceuticals マネジメント

マネジメント 基準チェック /34

Processa Pharmaceuticals'の CEO はGeorge Ngで、 Aug2023年に任命され、 の在任期間は 1 年未満です。 の年間総報酬は$ 714.03Kで、 22.3%給与と77.7%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.7%を直接所有しており、その価値は$ 35.00K 。経営陣と取締役会の平均在任期間はそれぞれ6.2年と4.3年です。

主要情報

George Ng

最高経営責任者

US$714.0k

報酬総額

CEO給与比率22.3%
CEO在任期間less than a year
CEOの所有権0.7%
経営陣の平均在職期間6.2yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Dec 12
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Oct 20
Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73

Aug 12

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Jul 07
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Jan 20
We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Aug 26
Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Processa Pharmaceuticals (PCSA) Presents At LD Micro Invitations XI Virtual Conference - Slideshow

Jun 15

What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Mar 15
What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Processa Pharmaceuticals: Multiple Shots On Goal With Total TAM Of $8B - Worth A Look

Jan 29

How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

Jan 20
How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

CEO報酬分析

Processa Pharmaceuticals の収益と比較して、George Ng の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$714kUS$159k

-US$11m

報酬と市場: Georgeの 総報酬 ($USD 714.03K ) は、 US市場 ($USD 674.64K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Georgeの報酬と会社の業績を比較するにはデータが不十分です。


CEO(最高経営責任者

George Ng (50 yo)

less than a year

在職期間

US$714,031

報酬

Mr. George K. Ng, Esq. JD serves as CEO of Processa Pharmaceuticals, Inc. since August 08, 2023 and serves as its Director since August 08, 2023 and served as its Director since August 08 2023 until 2024....


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
George Ng
CEO & Directorless than a yearUS$714.03k0.70%
$ 35.0k
David Young
Co-Founder7.4yrsUS$186.64k3.48%
$ 173.9k
Sian Bigora
Co-Founder and Chief Development & Regulatory Officerno dataUS$321.73k0.75%
$ 37.6k
James Stanker
Chief Financial Officer5.8yrsUS$342.62k0.21%
$ 10.7k
Patrick Lin
Co-Founder7.4yrsUS$1.04m1%
$ 50.1k
Wendy Guy
Co-Founder6.7yrsUS$1.02m0.40%
$ 20.0k
Steven Cha
Senior Vice President of Clinical Researchless than a yearデータなしデータなし

6.2yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: PCSAの経営陣は経験豊富で経験豊富です(平均在職期間は6.2年)。


取締役

名称ポジション在職期間報酬所有権
George Ng
CEO & Directorless than a yearUS$714.03k0.70%
$ 35.0k
David Young
Co-Founder6.7yrsUS$186.64k3.48%
$ 173.9k
James Neal
Independent Director1.9yrsUS$83.00k0.025%
$ 1.3k
John Devane
Member of Medical & Scientific Advisory Board4.3yrsデータなしデータなし
Justin Yorke
Independent Chairman of Board6.8yrsUS$54.00k0.13%
$ 6.5k
James Shipley
Member of Medical & Scientific Advisory Board4.3yrsデータなしデータなし
Stuart Madden
Member of Medical & Scientific Advisory Board1.7yrsデータなしデータなし
Khoso Baluch
Independent Director1.9yrsUS$83.00k0.049%
$ 2.4k
Geraldine Pannu
Independent Director4.3yrsUS$54.00k0.10%
$ 5.0k

4.3yrs

平均在職期間

61.5yo

平均年齢

経験豊富なボード: PCSAの 取締役会経験豊富 であると考えられます ( 4.3年の平均在任期間)。